Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

14
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

956
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
956
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

15
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

14
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

557
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
557

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ayush Bala Rakshak Leham for Moderate Malnutrition in Children Aged 3 to 5 Years: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Estimation of prevalence of pneumoconiosis among Indian dental healthcare professionals - an analytical cross-sectional study.

International journal of occupational safety and ergonomics : JOSE·2026
Same author

Phage biocontrol reduces the disease burden and modulates plant immunity through suppression of bacterial virulence.

Cell reports·2026
Same author

Effectiveness of a game-based oral health intervention on plaque and gingival scores among schoolchildren: A nonrandomized controlled trial.

Journal of Indian Society of Periodontology·2026
Same author

Parental Preparedness for Traumatic Dental Injury Management in Children - An Evaluative Study.

Indian journal of dental research : official publication of Indian Society for Dental Research·2026
Same author

Role of an Ayurvedic formulation 'Kalyanaka Ghrita' in mild cognitive impairment: A single-patient, quasi-randomized, controlled, open-label N-of-1 trial.

Journal of ethnopharmacology·2026

Related Experiment Video

Updated: Jul 13, 2025

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

8.8K

Microvascular Dysfunction in Obesity-Hypertension.

Tammy Do1, Ashley Van1, Arash Ataei1

  • 1Department of Medicine, LSU Health Sciences Center - New Orleans, New Orleans, LA, USA.

Current Hypertension Reports
|October 14, 2023
PubMed
Summary
This summary is machine-generated.

Microvascular dysfunction plays a key role in obesity-hypertension. Newer therapies show promise for improving this condition, but more research is needed for precision treatments.

Keywords:
Microvascular dysfunctionObesity-hypertensionVascular rarefaction

More Related Videos

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
07:24

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

7.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.3K

Related Experiment Videos

Last Updated: Jul 13, 2025

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

8.8K
Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
07:24

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

7.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.3K

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Metabolic Diseases

Background:

  • Obesity and hypertension are strongly linked, but the underlying mechanisms remain unclear.
  • Microvascular dysfunction is implicated in both obesity and hypertension, potentially mediating obesity-related hypertension.
  • Understanding this complex interplay is crucial for developing effective treatments.

Purpose of the Study:

  • To review the role of microvascular dysfunction in obesity-hypertension.
  • To discuss obesity's impact on renal microvasculature.
  • To examine current assessment methods and therapeutic options for microvascular dysfunction.

Main Methods:

  • Literature review of studies on obesity, hypertension, and microvascular function.
  • Analysis of the effects of obesity on renal microvasculature.
  • Evaluation of emerging therapeutic strategies.

Main Results:

  • Microvascular dysfunction is a significant factor in obesity-hypertension.
  • Emerging therapies like GLP-1 agonists and SGLT-2 inhibitors may improve microvascular function.
  • Further research is essential to elucidate the intricate relationship between obesity, hypertension, and microvascular health.

Conclusions:

  • Microvascular dysfunction is a critical link between obesity and hypertension.
  • Novel pharmacological agents offer potential benefits for managing obesity-hypertension.
  • Continued investigation is vital for advancing precision medicine approaches to target obesity-hypertension.